Archive for the ‘Injectable Fillers’ Category

Measuring First Impressions After Hyaluronic Acid Filler Injection

Friday, November 12th, 2010

restylane-savannah-gaDoes wrinkle correction change the image you project to others? Surgeons at the Chicago Center for Facial Plastic Surgery sought to answer that question in a recent paper published in Dermatologic Surgery.

Many studies have evaluated the physical results achieved with HA fillers like Restylane and Juvederm, but very few have documented the way other people perceive these cosmetic changes.

Using injections of hyaluronic acid filler, doctors fully corrected the nasolabial folds on 22 patients. To determine how treatment affected first impressions, they showed pictures of the patients to 304 people as blinded evaluators. They asked the evaluators about categories such as attractiveness, athletic ability, financial success, relationships and overall first impression.

“Significance was observed in all categories measured,” the authors conclude; “full correction of the NLFs with HA filler significantly and positively influences the first impression an individual projects.”

Funding and materials for the study were provided by Medicis, maker of Restylane. You can read the abstract or purchase access to this study on PubMed

Latest Data on Dysport Show Quick Correction of Glabellar Lines

Wednesday, October 27th, 2010

Compared to Botox, Dysport may provide faster correction of glabellar lines, say doctors at the 2010 Meeting of the American Society for Dermatologic Surgery.

According to Medscape news, during a session of the meeting, Dr. Joel Schlessinger of Omaha presented results of a phase 3 clinical trial evaluating the effectiveness of Dysport.

Based on his findings, the doctor concluded that results of Dysport take effect about 2 days faster than Botox®. “That can be very helpful for a person who is looking for a faster onset,” he reportedly said.

Get the whole story from Medscape.com

FDA Gives Clearance for Botox Headache Treatment

Saturday, October 16th, 2010

The U.S. Food and Drug Administration announced Friday that Botox, the popular anti wrinkle treatment, is now approved for the treatment of chronic migraine headaches. With this new application, therapeutic treatments with Botox may begin to surpass the number of cosmetic treatments performed.

People suffering from chronic migraines regularly experience an intense throbbing pain in one area of the head, a condition that’s often very debilitating. To help prevent migraines, Botox injections are administered every 12 weeks around the head and neck. The injections are only intended for treating severe headaches that occur more than 14 days in one month. Neurologists believe Botox migraine treatments may work by disrupting the transmission of pain signals to the nerve endings.

Some analysts believe that Botox sales will dramatically increase, while others remain unconvinced. According to an article in the New York Times, some argue that “minimal” effectiveness and high cost will prevent Botox from being embraced by most doctors and patients.

Read the FDA press release

New Botulinum Toxin Granted FDA Approval This Week

Tuesday, August 3rd, 2010

Merz Pharmaceuticals announced yesterday that FDA approval was granted for XEOMIN, a drug containing botulinum toxin.  The new drug is indicated for the treatment of cervical dystonia and blepharospasm.  Along with the relatively new Dysport and ubiquitous Botox®, Xeomin is the 3rd product of this kind to receive clearance in the U.S.

Two clinical trials were cited during the approval process, along with studies that compared XEOMIN to Botox®.  According to a study cited in the Journal of Neurological Sciences, [XEOMIN] showed “non-inferiority” to Botox® when used in equivalent doses for the treatment of blepharospasm.

The difference between XEOMIN and its competitors, according to the manufacturer Merz Pharmaceutical, is that “XEOMIN does not require refrigeration prior to reconstitution. “  The company says this could “simplify product distribution and storage, and help ensure product integrity at the time of injection.”

Merz is also acquiring Bioform Medical, a California company that manufactures Radiesse dermal filler.  The German company seems poised to create a significant presence in the U.S. aesthetics market.  When the acquisition of Bioform Medical is complete, the company will be rebranded “Merz Aesthetics.”

Don’t miss Artefill Day, July 9

Sunday, June 6th, 2010

Don’t miss your chance to experience Artefill! Join Dr. Meghan McGovern to learn more about this long-lasting injectable filler.

Friday, July 9, 2010, 9am – 2pm

Meet our expert from Artefill. Discount pricing at event only. 

Must book appointment to qualify.

 Call Christy at 912-920-5613 now, times are filling fast!

What is Artefill?
Artefill is a microsphered enhanced long lasting collagen filler that allows you to keep the look you love!

How does it work?
Artefill is dual-acting wrinkle filler. Once injected deeply below the wrinkle, the collagen in Artefill acts as a temporary filler for immediate wrinkle correction. As your body absorbs the collagen over time, the microspheres remain in place and your body’s own new collagen is deposited on the surface of the microspheres. Your skin’s new collagen is what provides long-lasting, natural feeling wrinkle correction.

Call us at 912-920-2090 or contact us online to schedule your consultation today.